We are live on
!
Find out more
NPA
Nichols & Pratt Advisers Portfolio holdings
AUM
$1.55B
1-Year Est. Return
14.55%
This Fund
S&P 500
This Quarter
Est. Return
-16.66%
1 Year Est. Return
+14.55%
3 Year Est. Return
+54.54%
5 Year Est. Return
+81.09%
10 Year Est. Return
+238.91%
AUM
$998M
AUM Growth
-$218M
(-18%)
Cap. Flow
+$3.98M
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
47.34%
Holding
95
New
1
Increased
57
Reduced
25
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$3.92M |
| 2 |
ExxonMobil
XOM
|
+$3.29M |
| 3 |
Amazon
AMZN
|
+$1.11M |
| 4 |
Microsoft
MSFT
|
+$802K |
| 5 |
Johnson & Johnson
JNJ
|
+$497K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$4.27M |
| 2 |
SLB Ltd
SLB
|
+$3.35M |
| 3 |
Gilead Sciences
GILD
|
+$2.97M |
| 4 |
Emerson Electric
EMR
|
+$688K |
| 5 |
Colgate-Palmolive
CL
|
+$595K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.29% |
| 2 | Healthcare | 22.69% |
| 3 | Consumer Staples | 16.97% |
| 4 | Industrials | 9.18% |
| 5 | Financials | 7.77% |
Similar funds
ZBNA
BGCP
MSA
PMFA
VWM
TNBTD
AC
1WM
Nichols & Pratt Advisers's Q1 2020 Portfolio in Review
As of Q1 2020, Nichols & Pratt Advisers held 95 positions worth $998M, down 18% from $1.22B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Nichols & Pratt Advisers's Q1 2020 filing shows 1 new, 57 increased, 25 reduced and 4 closed positions. Its largest new stake was Zoetis: 1,948 shares worth $229K. The largest sale was Walgreens Boots Alliance, an estimated $4.27M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Staples.
- Nichols & Pratt Advisers's largest Q1 2020 buy was Zoetis: 1,948 shares worth $229K.
- Nichols & Pratt Advisers added most to CVS Health in Q1 2020, an estimated $3.92M increase.
- Nichols & Pratt Advisers's biggest Q1 2020 reduction was Walgreens Boots Alliance, cutting an estimated $4.27M.
- Nichols & Pratt Advisers fully exited Gilead Sciences in Q1 2020, selling an estimated $2.97M.
- Nichols & Pratt Advisers's ten largest holdings make up 47% of its $998M portfolio in Q1 2020.
- Nichols & Pratt Advisers opened 1 new position and closed 4 in Q1 2020.
- Nichols & Pratt Advisers's portfolio value fell 18% quarter-over-quarter to $998M.
Based on Nichols & Pratt Advisers's 13F filing for Q1 2020, filed 24 Apr 2020.